Cytogen, Inc. (KOSDAQ:217330)
South Korea · Delayed Price · Currency is KRW 3,945.00
-95.00 (-2.35%)
At close: Apr 9, 2026
Cytogen Market Cap
Cytogen has a market cap or net worth of 91.01 billion as of April 10, 2026. Its market cap has decreased by -9.00% in one year.
Market Cap
91.01B
Enterprise Value
76.21B
Revenue
26.05B
Ranking
n/a
PE Ratio
n/a
Stock Price
3,945.00
Market Cap Chart
Since November 22, 2018, Cytogen's market cap has increased from 87.89B to 91.01B, an increase of 3.55%. That is a compound annual growth rate of 0.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 8, 2026 | 93.20B | -55.06% |
| Dec 30, 2025 | 207.40B | 98.24% |
| Dec 30, 2024 | 104.62B | -59.34% |
| Dec 28, 2023 | 257.28B | -11.12% |
| Dec 29, 2022 | 289.47B | -18.62% |
| Dec 30, 2021 | 355.72B | 47.87% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 22, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dx & Vx | 494.11B |
| 3billion | 380.82B |
| GENINUS | 163.08B |
| HLB Panagene | 108.90B |
| Green Cross Medical Science | 79.79B |
| Protia | 60.20B |
| Seoulin Bioscience | 54.46B |
| GeneMatrix | 39.38B |